# How Continuous Glucose Monitors Estimate Blood Sugar Levels Accurately > This patent describes a method for accurately estimating blood glucose levels by accounting for the natural delay in glucose moving between interstitial fluid and blood, using sensor data and its rate of change. - **Patent:** US 8882665 - **Original title:** Method and/or system for multicompartment analyte monitoring - **Owner:** Medtronic Minimed - **Granted:** 2014 - **Status:** Active - **Times cited:** 9 - **Field:** biotech, medical_devices, software, consumer_electronics ## What it does The patent describes a system and method (Claim 1, 13) for monitoring a substance, called an "analyte," in the body. It specifically focuses on estimating the analyte's concentration in a "first physiological compartment" (like blood plasma, Claim 2) by taking measurements from a "second physiological compartment" (like interstitial fluid, Claim 2). The system "models a latency" (a delay) in how the analyte moves between these two compartments and then "compensates for the latency" when calculating the final estimate. For example, if a continuous glucose monitor (CGM) measures glucose in the interstitial fluid, a processor predicts the blood glucose level, even though there's a natural time lag for glucose to move. This compensation uses not just the current sensor reading, but also the "estimated rate of change" of that sensor signal (Claim 1) to improve accuracy. ## What it does NOT cover - Does not cover systems that measure analyte levels directly in the first physiological compartment (e.g., a finger-prick blood glucose meter). - Does not cover methods that estimate analyte concentration without accounting for the latency between two compartments. - Does not cover systems that only use a single measurement value without considering the rate of change of the sensor signal for latency modeling. - Does not cover methods where the "first physiological compartment" is not blood plasma or the "second physiological compartment" is not interstitial fluid, if glucose is the analyte (Claim 2 specifies this common scenario). ## The clever bit The key innovation is recognizing and mathematically compensating for the time delay (latency) in how an analyte, like glucose, moves between different body fluids. By using the *rate of change* of the sensor signal, the system can better predict future or current blood glucose levels, even when the interstitial fluid reading lags behind. ## Real-world examples 1. Medtronic Guardian Connect CGM 2. Dexcom G-series CGMs 3. Abbott FreeStyle Libre 4. Most modern continuous glucose monitoring (CGM) systems ## Why it matters This technology is fundamental to continuous glucose monitoring (CGM) devices, which are critical for managing diabetes. By accurately estimating blood glucose from interstitial fluid, it allows people with diabetes to track their glucose trends in real-time without frequent finger-prick tests. This improves daily management, helps prevent dangerous high or low blood sugar events, and informs insulin dosing decisions. ## Frequently asked questions ### What does How Continuous Glucose Monitors Estimate Blood Sugar Levels Accurately cover? This patent describes a method for accurately estimating blood glucose levels by accounting for the natural delay in glucose moving between interstitial fluid and blood, using sensor data and its rate of change. ### Who owns patent US 8882665? Medtronic Minimed owns this patent, granted in 2014. ### When does this patent expire? This patent is expected to expire on October 26, 2031, when the invention enters the public domain. ### What is patent US 8882665 cited by? This patent has been cited by 9 later patents that build on its ideas. ### What problem does this patent solve? This technology is fundamental to continuous glucose monitoring (CGM) devices, which are critical for managing diabetes. By accurately estimating blood glucose from interstitial fluid, it allows people with diabetes to track their glucose trends in real-time without frequent finger-prick tests. This improves daily management, helps prevent dangerous high or low blood sugar events, and informs insulin dosing decisions. ### What does this patent NOT cover? Does not cover systems that measure analyte levels directly in the first physiological compartment (e.g., a finger-prick blood glucose meter). **Full plain-English explainer:** https://patentbrief.org/patent/us/8882665/method-andor-system-for-multicompartment-analyte-monitoring-8882665 **Original patent:** https://patents.google.com/patent/US8882665 --- _Source: PatentBrief — https://patentbrief.org. Patent facts are from public records; the plain-English explanation is PatentBrief's._ ## Related patents Semantically similar inventions in the PatentBrief corpus: - [How Devices Precisely Track Glucose Across Body Compartments](https://patentbrief.org/patent/us/9854998/method-andor-system-for-multicompartment-analyte-monitoring) — This patent describes a method for accurately estimating a person's blood glucose by accounting for the natural time delay in how glucose moves between different body fluids, like blood and the fluid around cells, to better control insulin pumps. - [How a Sensor Checks Itself for Accuracy Using Other Body Data](https://patentbrief.org/patent/us/20230263439/systems-and-methods-for-multi-analyte-sensing) — This patent describes a smart system that uses additional body measurements or relationships between different body chemicals to figure out if an analyte sensor, like a glucose monitor, is giving wrong readings and then fixes it or tells you to replace it. - [How a Computer System Automatically Adjusts Blood Sugar in Real-Time](https://patentbrief.org/patent/us/8956321/computerized-system-for-blood-chemistry-monitoring) — This patent describes a computerized system that continuously monitors a patient's blood glucose and automatically adjusts insulin and dextrose delivery to keep blood sugar levels stable, especially for critically ill patients. - [How Glucose Sensors Check Their Own Reliability for Insulin Pumps](https://patentbrief.org/patent/us/9282925/systems-and-methods-for-replacing-signal-artifacts-in-a-glucose-sensor-data-stre) — This patent describes a system that automatically checks how trustworthy a continuous glucose sensor's readings are and then adjusts how an insulin pump delivers medicine based on that trust level. - [A Catheter That Measures Glucose While Delivering Medication](https://patentbrief.org/patent/us/11382539/analyte-sensor) — This patent describes a medical system that combines a catheter for delivering medication with a continuous glucose sensor built directly onto its surface, allowing for simultaneous monitoring and therapy.